Skip to Main Content

Author Details

Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
1998
141
36
PMIDPaper TitleJournal TitlePublished Year
37979707Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).Int J Radiat Oncol Biol Phys2024
37633499Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability.Int J Radiat Oncol Biol Phys2024
35948465Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes.Clin Oncol (R Coll Radiol)2023
37619656Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer.Radiother Oncol2023
37739608Elective Nodal Irradiation: Old Game, New SPORT.Int J Radiat Oncol Biol Phys2023
37546794Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.bioRxiv2023
37604988Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer.Sci Rep2023
37419394To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2023
37414253Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.Radiother Oncol2023
37439544Native Mass Spectrometry Quantitation of α2-3-Linked <i>N</i>-Acetylneuraminic Acid Content of Prostate-Specific Antigen: An Accurate Liquid Biopsy for Clinically Significant Prostate Cancer.Anal Chem2023
37437609Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.Radiother Oncol2023
36754232Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial.Radiother Oncol2023
36750891Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience.Radiat Oncol2023
36462619Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy.Pract Radiat Oncol2023
36493331Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.J Clin Oncol2023
35907615Minimizing the Risk of Acute Skin Toxicity Due to Hip Prosthesis Avoidance in Prostate Radiation Therapy.Pract Radiat Oncol2023
34103388Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression.J Clin Pathol2022
35616948Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial.JAMA Oncol2022
35732815An appraisal of genetic testing for prostate cancer susceptibility.NPJ Precis Oncol2022
36132128Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.Front Oncol2022
36230835Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification.Cancers (Basel)2022
36077685The Effect of Age on Prostate Cancer Survival.Cancers (Basel)2022
35302473Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.Can Urol Assoc J2022
35027623Upregulation of IFNÉ£-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.Sci Rep2022
34993496Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG Adv2022
34896065Case series of radiation pneumonitis in breast cancer.J Med Imaging Radiat Sci2022
34637882Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost.Int J Radiat Oncol Biol Phys2022
32471889Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study.J Clin Pathol2021
33775496Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer - Results from a Prospective Cohort Study.Clin Oncol (R Coll Radiol)2021
34474211Why Do Older Women Avoid Breast Cancer Surgery? A Qualitative Analysis of Decision-Making Factors.J Surg Res2021
34406870Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.J Clin Oncol2021
34487764Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials.Radiother Oncol2021
34453155Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.Nat Rev Urol2021
34503355Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.J Urol2021
34324914Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.Radiother Oncol2021
34089752Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life.Radiother Oncol2021
34171218The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.Can Urol Assoc J2021
33172830Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study.Radiother Oncol2021
33007183When to biopsy Prostate Imaging and Data Reporting System version 2 (PI-RADSv2) assessment category 3 lesions? Use of clinical and imaging variables to predict cancer diagnosis at targeted biopsy.Can Urol Assoc J2021
32949772A Feasibility Study of Mepitel Film for the Prevention of Breast Radiation Dermatitis in a Canadian Center.Pract Radiat Oncol2021
31161221Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.J Natl Cancer Inst2020
31809979Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.Radiother Oncol2020
31919144Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder.J Clin Pathol2020
31708295Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.Eur Urol2020
32861170Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.Pathol Res Pract2020
33022560Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?Pathol Res Pract2020
32362536Factors Affecting Mean Heart Dose in Patients Receiving Breast Radiotherapy from 2011 to 2018 in a Single Institution.J Med Imaging Radiat Sci2020
32416376Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT).Radiother Oncol2020
32540281Trends and Correlates of Mean Lung Dose in Patients Receiving Breast Radiotherapy in a Single Institution from 2014 to 2018.Clin Oncol (R Coll Radiol)2020
32321680Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.Clin Breast Cancer2020
  • 1 - 50 of 141

Recommended Authors

Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2010
Number of shared co-authors 25
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 19
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 10
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 6
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 10
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 30
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 17
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 16
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 20
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 5
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 6
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 18
Felix Y Feng
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 33
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 15
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 6
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 11
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 7
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 8
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 10
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 12
David Joseph
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 5
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 19
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 8
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 35
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 18
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 13
Oliver Sartor
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 21
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 14
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 15

Collaborators

Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 42
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers 36
Edward Chow
University of Toronto
Co-authored papers 18
Michelle R Downes
University of Toronto
Co-authored papers 15
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 10
Robert G Bristow
University of Toronto
Co-authored papers 9
Neil E Fleshner
University of Toronto
Co-authored papers 9
Kristina Commisso
University Health Network
Co-authored papers 7
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Bharati Bapat
Mt Sinai Hospital
Co-authored papers 5
Fang Zhao
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 5
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 5
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Co-authored papers 5
Masoom A Haider
University Health Network
Co-authored papers 5
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 4
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 4
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 4
Paul C Boutros
University of California los angeles
Co-authored papers 4
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 4
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 4
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 3
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Renu Jeyapala
Toronto Metropolitan University
Co-authored papers 3
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 3
Sahar Jahangiri
Tehran University of Medical Sciences
Co-authored papers 3
Aruz Mesci
Juravinski Cancer Centre
Co-authored papers 3
Seville Scarcello
Sunnybrook Research Institute
Co-authored papers 2
Dirk G Kieback
Helios Medical Centre
Co-authored papers 2
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Co-authored papers 2
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 2
Release 1.2